Hepatitis Monthly

Published by: Kowsar

World Hepatitis Day in Burkina Faso, 2016: Awareness, Screening, Identification of HBV Markers, HBV/HCV Coinfection, and Vaccination

Birama Diarra 1 , 2 , Abdoul Karim Ouattara 1 , 2 , Florencia Wendkuuni Djigma 1 , 2 , Tegwinde Rebeca Compaore 1 , 2 , Dorcas Obiri-Yeboah 3 , Lassina Traore 1 , 2 , Serge Theophile Soubeiga 1 , 2 , Prosper Bado 1 , 2 , Justine Yara 4 , Virginio Pietra 1 , Paul Ouedraogo 5 , Alain Bougouma 6 , Rokia Sanogo 7 and Jacques Simpore 1 , 2 , *
Authors Information
1 Biomolecular Research Center PietroAnnigoni (CERBA), BP 364 Ouagadougou 01, Burkina Faso
2 Laboratory of Molecular Biology and Molecular Genetics (LABIOGENE) UFR/SVT, University Ouaga I Prof Joseph KI-ZERBO, Burkina Faso; BP 7021 Ouagadougou 03
3 Department of Microbiology and Immunology, School of Medical Sciences, University of Cape Coast, Ghana
4 SOS Hepatitis Burkina Faso
5 Saint Camille Hospital of Ouagadougou (HOSCO), BP 444 Ouagadougou 01, Burkina Faso
6 Gastroenterology Service, CHU Yalgado OUEDRAOGO, Ouagadougou, Burkina Faso
7 Faculty of Pharmacy, University of Sciences of Techniques and Technologies of Bamako (USTTB), Mali
Article information
  • Hepatitis Monthly: June 2017, 17 (6); e13789
  • Published Online: May 31, 2017
  • Article Type: Research Article
  • Received: December 8, 2016
  • Revised: February 10, 2017
  • Accepted: February 13, 2017
  • DOI: 10.5812/hepatmon.13789

To Cite: Diarra B, Ouattara A K, Wendkuuni Djigma F, Rebeca Compaore T, Obiri-Yeboah D, et al. World Hepatitis Day in Burkina Faso, 2016: Awareness, Screening, Identification of HBV Markers, HBV/HCV Coinfection, and Vaccination, Hepat Mon. 2017 ;17(6):e13789. doi: 10.5812/hepatmon.13789.

Abstract
Copyright © 2017, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Stanaway JD, Flaxman AD, Naghavi M, Fitzmaurice C, Vos T, Abubakar I, et al. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. Lancet. 2016; 388(10049): 1081-8[DOI][PubMed]
  • 2. Livinec B. Estimating the burden of hepatitis. Lancet. 2016; 388(10061): 2738-9[DOI][PubMed]
  • 3. Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006; 45(4): 529-38[DOI][PubMed]
  • 4. Pozzetto B, Garraud O. [Emergent viral threats in blood transfusion]. Transfus Clin Biol. 2011; 18(2): 174-83[DOI][PubMed]
  • 5. Konstantinou D, Deutsch M. The spectrum of HBV/HCV coinfection: epidemiology, clinical characteristics, viralinteractions and management. Ann Gastroenterol. 2015; 28(2): 221-8[PubMed]
  • 6. Simpore J, Savadogo A, Ilboudo D, Nadambega MC, Esposito M, Yara J, et al. Toxoplasma gondii, HCV, and HBV seroprevalence and co-infection among HIV-positive and -negative pregnant women in Burkina Faso. J Med Virol. 2006; 78(6): 730-3[DOI][PubMed]
  • 7. Nagalo MB, Sanou M, Bisseye C, Kabore MI, Nebie YK, Kienou K, et al. Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis among blood donors in Koudougou (Burkina Faso) in 2009. Blood Transfus. 2011; 9(4): 419-24[DOI][PubMed]
  • 8. Tao I, Compaore TR, Diarra B, Djigma F, Zohoncon TM, Assih M, et al. Seroepidemiology of hepatitis B and C viruses in the general population of burkina faso. Hepat Res Treat. 2014; 2014: 781843[DOI][PubMed]
  • 9. Pietra V, Kiema D, Sorgho D, Kabore SP, Mande S, Castelli F, et al. Prevalence des marqueurs du virus de l’hepatite B et des anticorps contre le virus de l’hepatite C parmi le personnel du District Sanitaire de Nanoro, Burkina Faso. Sciences et Techniques, Sciences de la Sante. 2008; 31: 53-9
  • 10. Simpore J, Granato M, Santarelli R, Nsme RA, Coluzzi M, Pietra V, et al. Prevalence of infection by HHV-8, HIV, HCV and HBV among pregnant women in Burkina Faso. J Clin Virol. 2004; 31(1): 78-80[DOI][PubMed]
  • 11. Zeba MT, Karou SD, Sagna T, Djigma F, Bisseye C, Ouermi D, et al. HCV prevalence and co-infection with HIV among pregnant women in Saint Camille Medical Centre, Ouagadougou. Trop Med Int Health. 2011; 16(11): 1392-6[DOI][PubMed]
  • 12. Pol S, Corouge M. Treatment of hepatitis C: perspectives. Med Mal Infect. 2014; 44(10): 449-54[DOI][PubMed]
  • 13. Towards elimination of viral hepatitis by 2030. Lancet. 2016; 388(10042): 308[DOI][PubMed]
  • 14. Brahm J, Castera L, Hou J, Lindor K. Joint society statement for the elimination of viral hepatitis. Hepatology. 2016; 64(4): 1031-2[DOI][PubMed]
  • 15. Chizzali-Bonfadin C, Adlassnig KP, Kreihsl M, Hatvan A, Horak W. Knowledge-based interpretation of serologic tests for hepatitis on the World Wide Web. Clin Perform Qual Health Care. 1997; 5(2): 61-3[PubMed]
  • 16. ter Borg F, ten Kate FJ, Cuypers HT, Leentvaar-Kuijpers A, Oosting J, Wertheim-van Dillen PM, et al. Relation between laboratory test results and histological hepatitis activity in individuals positive for hepatitis B surface antigen and antibodies to hepatitis B e antigen. Lancet. 1998; 351(9120): 1914-8[PubMed]
  • 17. Van der Poel CL, Cuypers HT, Reesink HW, Weiner AJ, Quan S, Di Nello R, et al. Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. Lancet. 1991; 337(8737): 317-9[PubMed]
  • 18. Collenberg E, Ouedraogo T, Ganame J, Fickenscher H, Kynast-Wolf G, Becher H, et al. Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: A comparative analysis. J Med Virol. 2006; 78(5): 683-92[DOI][PubMed]
  • 19. Tao I, Bisseye C, Nagalo BM, Sanou M, Kiba A, Surat G, et al. Screening of Hepatitis G and Epstein-Barr Viruses Among Voluntary non Remunerated Blood Donors (VNRBD) in Burkina Faso, West Africa. Mediterr J Hematol Infect Dis. 2013; 5(1)[DOI][PubMed]
  • 20. Samal J, Kandpal M, Vivekanandan P. Molecular mechanisms underlying occult hepatitis B virus infection. Clin Microbiol Rev. 2012; 25(1): 142-63[DOI][PubMed]
  • 21. Gerlich WH. Diagnostic problems caused by HBsAg mutants-a consensus report of an expert meeting. Intervirology. 2004; 47(6): 310-3[PubMed]
  • 22. Seo DH, Whang DH, Song EY, Han KS. Occult hepatitis B virus infection and blood transfusion. World J Hepatol. 2015; 7(3): 600-6[DOI][PubMed]
  • 23. Yoshikawa A, Gotanda Y, Minegishi K, Taira R, Hino S, Tadokoro K, et al. Lengths of hepatitis B viremia and antigenemia in blood donors: preliminary evidence of occult (hepatitis B surface antigen-negative) infection in the acute stage. Transfusion. 2007; 47(7): 1162-71[DOI][PubMed]
  • 24. Makuwa M, Mintsa-Ndong A, Souquiere S, Nkoghe D, Leroy EM, Kazanji M. Prevalence and molecular diversity of hepatitis B virus and hepatitis delta virus in urban and rural populations in northern Gabon in central Africa. J Clin Microbiol. 2009; 47(7): 2265-8[DOI][PubMed]
  • 25. Harania RS, Karuru J, Nelson M, Stebbing J. HIV, hepatitis B and hepatitis C coinfection in Kenya. AIDS. 2008; 22(10): 1221-2[DOI][PubMed]
  • 26. Nagalo BM, Bisseye C, Sanou M, Kienou K, Nebie YK, Kiba A, et al. Seroprevalence and incidence of transfusion-transmitted infectious diseases among blood donors from regional blood transfusion centres in Burkina Faso, West Africa. Trop Med Int Health. 2012; 17(2): 247-53[DOI][PubMed]
  • 27. Serme AK, Ilboudo PD, Samandoulgou A, Simpore J, Bougouma A, Sombie AR. [Prevalence of Hepatitis C virus infection in pregnant women and mother-child transmission in Ouagadougou, Burkina Faso]. Bull Soc Pathol Exot. 2006; 99(2): 108-9[PubMed]
  • 28. Simpore J, Ilboudo D, Samandoulougou A, Guardo P, Castronovo P, Musumeci S. HCV and HIV co-infection in pregnant women attending St. Camille Medical Centre in Ouagadougou (Burkina Faso). J Med Virol. 2005; 75(2): 209-12[DOI][PubMed]
  • 29. Zeba MT, Ouattara CA, Karou SD, Bisseye C, Ouermi D, Djigma FW, et al. Prevalence of HBV and HCV markers among patients attending the Saint Camille Medical Centre in Ouagadougou. Pak J Biol Sci. 2012; 15(10): 484-9[PubMed]
  • 30. Halima SB, Bahri O, Maamouri N, Cheikh I, Alaya NB, Sadraoui A, et al. Serological and molecular expression of Hepatitis B infection in patients with chronic Hepatitis C from Tunisia, North Africa. Virol J. 2010; 7: 229[DOI][PubMed]
  • 31. Ilboudo D, Sawadogo A, Simpore J. [Mother-to-child transmission of hepatitis B virus, in Ouagadougou, Burkina Faso]. Med Trop (Mars). 2002; 62(1): 99-101[PubMed]
  • 32. Sangare L, Sombie R, Combassere AW, Kouanda A, Kania D, Zerbo O, et al. [Antenatal transmission of hepatitis B virus in an area of HIV moderate prevalence, Burkina Faso]. Bull Soc Pathol Exot. 2009; 102(4): 226-9[PubMed]
  • 33. McMahon BJ. Natural history of chronic hepatitis B. Clin Liver Dis. 2010; 14(3): 381-96[DOI][PubMed]
  • 34. Pande C, Sarin SK, Patra S, Kumar A, Mishra S, Srivastava S, et al. Hepatitis B vaccination with or without hepatitis B immunoglobulin at birth to babies born of HBsAg-positive mothers prevents overt HBV transmission but may not prevent occult HBV infection in babies: a randomized controlled trial. J Viral Hepat. 2013; 20(11): 801-10[DOI][PubMed]
  • 35. Mulrooney-Cousins PM, Michalak TI. Persistent occult hepatitis B virus infection: experimental findings and clinical implications. World J Gastroenterol. 2007; 13(43): 5682-6[PubMed]
  • 36. Mulrooney-Cousins PM, Michalak TI. Asymptomatic Hepadnaviral Persistence and Its Consequences in the Woodchuck Model of Occult Hepatitis B Virus Infection. J Clin Transl Hepatol. 2015; 3(3): 211-9[DOI][PubMed]
  • 37. Sondlane TH, Mawela L, Razwiedani LL, Selabe SG, Lebelo RL, Rakgole JN, et al. High prevalence of active and occult hepatitis B virus infections in healthcare workers from two provinces of South Africa. Vaccine. 2016; 34(33): 3835-9[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments